Timo Minssen

Timo Minssen

Professor

ORCID: 0000-0002-3286-4888

Publication year:
All
1 - 10 out of 226Page size: 10
Sort by: Title
  1. Published

    “Patenting Bioprinting Technologies in the US and Europe– The 5th element in the 3rd dimension"

    Minssen, Timo & Mimler, M., 2017, 3D printing, Intellectual Property and Innovation – Insights from Law and Technology. Ballardini, R. M., Norrgård, M. & Partanen, J. (eds.). Wolters Kluwer , p. 117-148 32 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  2. Published

    “Patenting Bioprinting Technologies in the US and Europe"

    Minssen, Timo & Mimler, M., 2016.

    Research output: Working paper

  3. Published

     AI, BIG DATA & MACHINE LEARNING – 2020, 2nd EDITION- Chapter on DENMARK

    Minssen, Timo, Goldschmieding, T. & Sandfeld Jakobsen, S., 22 May 2020, AI, BIG DATA & MACHINE LEARNING – 2020, 2nd EDITION. 2 ed. Global Legal Insights (GLI), p. 113-128 16 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research

  4. Published

    Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk

    Minssen, Timo & Schindler, G., 2008, In: Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil. 57, 3, p. 192 - 200 20 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?

    Wested, Jakob, Minssen, Timo & Van Zimmeren, E., 13 Jul 2018, In: Life Sciences Intellectual Property Review (LSIPR). 13/7 2018, 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Will mRNA Technology Companies Spawn Innovation Ecosystems?

    Grimpe, C., Minssen, Timo, Price II, W. N. & Stern, A., 18 Apr 2022, In: Harvard Business Review. 7 p.

    Research output: Contribution to journal › Journal article › Research

  7. Published

    Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

    Price II, W. N. & Minssen, Timo, Jul 2015, In: Nature Biotechnology. 33, 7, p. 685-686 2 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  8. Published

    Wie neue Anwendungen der mRNA -Technologie die Pharmabranche verändert

    Grimpe, C., Minssen, Timo, Price II, W. N. & Stern, A., Jul 2022, In: Harvard Business Manager.

    Research output: Contribution to journal › Comment/debate › Research

  9. Published

    When does stand-alone software qualify as a medical device in the European Union? The CJEU decision in SNITEM and what it implies for the next generation of medical devices

    Minssen, Timo, Mimler, M. & Mak, V., 1 Jul 2020, In: Medical Law Review. 28, 3, p. 615-624 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    What lurks in the shadows of the openness hyperbole for biopharmaceuticals?

    Rajam, N. & Minssen, Timo, 11 May 2019, In: Drug Development Research. 80, 3, p. 282-284 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...23 Next

ID: 16150437